Arthroplasty, Replacement, Hip Clinical Trial
Official title:
A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Secur-Fit Advanced Hip Stem
Verified date | April 2024 |
Source | Stryker Orthopaedics |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is a prospective, open-label, post-market, non-randomized, multi-center clinical evaluation of the Secur-Fit Advanced Hip Stem for primary total hip arthroplasty with a cementless application in a consecutive series of patients who meet the eligibility criteria. The success rate of the Secur-Fit Advanced femoral stem, defined as absence of stem revision for aseptic loosening or femoral fracture, is expected to be no worse than 99% at 5 years postoperative with a non-inferiority margin of 2.5%.
Status | Active, not recruiting |
Enrollment | 314 |
Est. completion date | May 1, 2028 |
Est. primary completion date | July 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years to 75 Years |
Eligibility | Inclusion Criteria: - Patient has signed an Institutional Review Board (IRB)/Ethics Committee (EC) approved, study specific Informed Patient Consent Form. - Patient is a male or non-pregnant female, skeletally mature and age 21-75 years at time of study device implantation. - Patient has a diagnosis of Non-Inflammatory Degenerative Joint Disease. - Patient is a candidate for primary total hip arthroplasty. - Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation. Exclusion Criteria: - Patient has previously undergone open surgical intervention on the operative hip. - Patient has a prior femoral fracture, with or without deformity, on the operative side. - Patient has an existing total hip replacement on the contralateral side. - Patient requires simultaneous bilateral total hip replacement. - Patient has a Body Mass Index (BMI) > 45. - Patient has an active or suspected latent infection in or about the affected hip joint at time of study device implantation. - Patient has a neuromuscular or neurosensory deficiency that would create an unacceptable risk of instability, prosthesis fixation failure or complications in postoperative care, or which limits the ability to evaluate the safety and efficacy of the device. - Patient has bone stock that is inadequate for support or fixation of the prosthesis, or is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's disease) leading to progressive bone deterioration. - Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. > 30 days). - Patient has a known sensitivity to device materials. - Patient is a prisoner. |
Country | Name | City | State |
---|---|---|---|
United States | OrthoNY - Everett Road Health Park | Albany | New York |
United States | University of Colorado Denver | Aurora | Colorado |
United States | Geisinger Orthopaedic Institute | Danville | Pennsylvania |
United States | Duke University Medical Center | Durham | North Carolina |
United States | Mercer Bucks Orthopaedics | Lawrenceville | New Jersey |
United States | Hospital for Special Surgery | New York | New York |
United States | Family Orthopedic Center | Spring Valley | Illinois |
United States | Tucson Orthopaedic Institute | Tucson | Arizona |
Lead Sponsor | Collaborator |
---|---|
Stryker Orthopaedics |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of revision for aseptic loosening or femoral fracture | 5 years | ||
Secondary | All-cause revision and removal rate | 10 years | ||
Secondary | Rate of femoral fracture | 30 days | ||
Secondary | Component exposure or countersink upon final seating | intraoperative | ||
Secondary | Femoral head center, femoral offset and leg-length discrepancy preoperative, planned and postoperative in a subset of cases | preop, 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Recruiting |
NCT03746925 -
Comparing Short-term Outcomes After Direct Anterior and SuperPATH Hip Arthroplasty Approaches
|
N/A | |
Completed |
NCT03008967 -
A Study of Patients Undergoing Total Knee and Hip Arthroplasty at a Regional Hospital in Denmark
|
N/A | |
Not yet recruiting |
NCT00958945 -
Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative Joint Replacements
|
N/A | |
Completed |
NCT00980616 -
Use of Local Analgesia With Epinephrine During Total Hip Arthroplasty (THA)
|
Phase 2 | |
Completed |
NCT04542174 -
PMCF 8 Year Results TRJ®
|
||
Not yet recruiting |
NCT04019925 -
Assessing the Wear Rates of the ADM/MDM Hips Using 3D X-ray Analysis
|
N/A | |
Recruiting |
NCT06102811 -
Low Concentration Local Anesthesia Fascia Iliaca Block for Total Hip Arthroplasty
|
N/A | |
Recruiting |
NCT03570944 -
Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol (POWER2)
|
||
Recruiting |
NCT02938962 -
Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X)
|
Phase 4 | |
Completed |
NCT03076827 -
Effects of Surgery Start Time on Postoperative Interleukin-6, Interleukin-8, and Cortisol
|
N/A | |
Recruiting |
NCT02385383 -
An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study
|
N/A | |
Completed |
NCT01444586 -
Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)
|
N/A | |
Terminated |
NCT02525627 -
A Comparative Study of In-vivo Wear Between 28 mm and 40 mm Metal Heads
|
N/A | |
Completed |
NCT00808483 -
Walking Skill Training Program Effects in Patients With Total Hip Arthroplasty
|
N/A | |
Terminated |
NCT00958347 -
Omnifit Hydroxylapatite (HA) Hip Outcomes Study
|
N/A | |
Completed |
NCT01422304 -
Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038)
|
Phase 3 | |
Completed |
NCT04332055 -
RCT Measuring the Effect of the ERVIN Software
|
N/A | |
Completed |
NCT01257568 -
Rejuvenate Modular Outcomes Study
|
N/A | |
Recruiting |
NCT01031732 -
Evaluation of Four Surgical Techniques in Primary Total Hip Arthroplasty
|
N/A |